Finance

Lists
Why is 603983 down 6.11%?
Dive Deeper
603983:SHA
Guangdong Marubi Biotechnology Co Ltd
CN¥25.64
-6.11%
(-1.67) 1D
Oct 15, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603983...
Open
CN¥27.00
High
CN¥27.06
Low
CN¥25.49
Mkt. cap
11.57B
Avg. vol.
4.76M
Volume
3.69M
Dividend
1.95%
Quarterly dividend
CN¥0.12
Ex-dividend date
Jul 16, 2026
P/E ratio
47.37
52-wk high
CN¥39.68
52-wk low
CN¥21.20
EPS
CN¥0.54
No. of employees
1K
Open
CN¥27.00
High
CN¥27.06
Low
CN¥25.49
Mkt. cap
11.57B
Avg. vol.
4.76M
Volume
3.69M
Dividend
1.95%
Quarterly dividend
CN¥0.12
Ex-dividend date
Jul 16, 2026
P/E ratio
47.37
52-wk high
CN¥39.68
52-wk low
CN¥21.20
EPS
CN¥0.54
No. of employees
1K
News stories
From web sources and news partners
About Guangdong Marubi Biotechnology Co Ltd
CEO-
Employees1.38K
FoundedApr 2, 2002
Headquarters-
SectorPersonal care products
Websitemarubi.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
681.19M
1.01B
881.29M
781.79M
Cost of goods sold
164.07M
278.10M
230.72M
209.66M
Cost of revenue
164.07M
278.10M
230.72M
209.66M
Research and development expenses
22.09M
22.58M
20.55M
24.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
465.72M
701.76M
505.93M
542.40M
Operating expense
489.86M
744.45M
531.68M
573.56M
Total operating expenses
653.93M
1.02B
762.40M
783.22M
Operating income
27.26M
-13.61M
118.89M
-1.43M
Other non operating income
-812.89K
-619.64K
-182.86K
127.50K
EBT including unusual items
57.75M
-2.79M
123.23M
59.61M
EBT excluding unusual items
45.95M
-1.29M
123.81M
62.37M
Income tax expense
-2.86M
-2.88M
22.23M
3.65M
Effective tax rate
-4.96%
103.35%
18.04%
6.13%
Other operating expenses
2.86M
20.49M
5.81M
6.55M
Net income
58.15M
3.35M
101.02M
54.45M
Net profit margin
8.54%
0.33%
11.46%
6.96%
Earnings per share
-
-
-
-
Interest and investment income
19.60M
13.50M
7.79M
63.49M
Interest expense
-33.31K
-592.98K
-2.68M
-
Net interest expenses
19.57M
12.90M
5.10M
63.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
32.64M
1.09M
133.59M
14.27M
Gain or loss from assets sale
377.40K
-377.40K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps